5:35 PM
 | 
Aug 20, 2014
 |  BC Extra  |  Company News

Pfizer, CCFA partner to fund IBD research

Pfizer Inc. (NYSE:PFE) and the Crohn's & Colitis Foundation of America will fund up to four academic projects focused on developing small molecules to treat Crohn's disease and ulcerative colitis. A committee comprising members from the...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >